Medical Disorders
Resources
Basic InformationLookupsLatest News
Insurance Often Covers Ivermectin for COVID, Even Though Drug Doesn't WorkCOVID Cases Surge Again in U.S. Nursing HomesCBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists SayCarbon Monoxide Deaths Soar During Power OutagesAHA News: Transplanting Pig Hearts Into Humans Offers Promise – and PerilCOVAX Program Has Now Sent 1 Billion COVID Vaccines to Poorer NationsCOVID Fatigue: Are You Among the 'Vaxxed & Done'?CDC Advises N95s as Best Masks Against CoronavirusYou Don't Have to Be a Smoker to Get Lung CancerSkipping COVID Vaccine in Pregnancy Brings Big Risks to Mothers, BabiesMasks Cut Distance Coronavirus Travels in Half, Study Finds1 in 10 People With COVID Still Infectious After 10 Days: StudyWorried About Omicron? Expert Offers Tips on Going Out SafelySupreme Court Blocks Biden's Vaccine Mandate for Large EmployersCould the 'Mono' Virus Help Trigger Multiple Sclerosis?AHA News: Obesity Harms Brain Health Throughout Life – Yet Scientists Don't Know WhyWhite House May Soon Offer 'High-Quality' Masks to AmericansCOVID Hospitalizations Rising in Kids Too Young for VaccineProgress on Lung Cancer Drives Overall Decline in U.S. Cancer DeathsNearly 600,000 U.S. Kids Had COVID Last WeekWildfires Plus Heat Make Breathing Dangerous in America's WestHow Safe Is a 'Holiday' From Bone-Strengthening Meds?White House to Give Schools 10 Million Free COVID Tests Every MonthBinaxNOW Test Catches COVID Infection in Many People, Study ShowsU.S. May Soon See Sharp Drop in Omicron Cases, Experts SayAs Omicron Rages, How Important Are Case Counts Anymore?Americans Should Avoid Travel to Canada: CDCRed Cross Says U.S. Blood Supply at Dangerously Low LevelPfizer Says Omicron-Specific Vaccine Ready by MarchRain or Shine, Allergies Are Tough. What's the Link to Weather?U.S. Insurers Must Cover 8 COVID At-Home Tests a Month: White HouseU.S. COVID Hospitalizations Pass Last Winter's PeakIn Breakthrough Transplant, Man Receives Genetically Modified Pig HeartExposure to Common Cold Might Help Shield Against COVIDDrug Combo Boosts Outcomes for Advanced MelanomaDo Not Use At-Home COVID Test Swabs in the Throat: FDAEven Symptom-Free, People With Omicron Much More Likely to Spread COVID: StudiesWant to Avoid Glaucoma? Look at What You EatNew Worry: 'Flurona,' When COVID Meets the FluAmid COVID Test Shortages, Price Gouging Is on the RiseNeed an At-Home COVID Test? Here's Help Finding and Using OneKnow Your Thyroid FactsFDA Shortens Time to Booster After Moderna Vaccine to 5 MonthsCOVID Vaccine May Temporarily Add 1 Day to Menstrual Cycle: StudyHospitals Are Rationing COVID Pills, Infusions as Cases RiseBreakthrough COVID Cases Overwhelmingly Mild for Vaccinated People: StudySupreme Court Hears Arguments on Biden's Vaccine Mandate for Big BusinessMore Evidence That State Lotteries Didn't Boost Vaccination RatesWhite House Finalizes Plan to Send Americans Free COVID Rapid TestsModerna CEO Says 4th COVID Dose May Be Needed Next Fall
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

BinaxNOW Test Catches COVID Infection in Many People, Study Shows

HealthDay News
by Robert Preidt and Robin Foster
Updated: Jan 12th 2022

new article illustration

WEDNESDAY, Jan. 12, 2022 (HealthDay News) -- Countering earlier concerns, a real-world study finds that a widely used at-home coronavirus test called BinaxNOW is as effective at detecting Omicron as other COVID-19 variants.

The study of Abbot's rapid antigen test included more than 700 people who visited a walk-up testing site in San Francisco.

The test detected 65% of infections caught by more sensitive PCR tests, but pinpointed 95% of people with the highest levels of the virus. Among those with high levels of the virus, the test identified 98% of those with symptoms and 90% of those without symptoms.

The results are about the same as what was found in real-world studies before Omicron emerged, according to the researchers.

The test is "working as it was designed,” study author Joseph DeRisi, a biochemist at the University of California, San Francisco, told The New York Times. “There does not seem to be any performance deficit with Omicron.”

The study, published on the preprint server medRxiv, has not yet been peer-reviewed.

Some earlier preliminary studies had raised questions about whether rapid antigen tests might be less sensitive to Omicron than other variants.

Scientists are still trying to determine how well at-home tests work for Omicron, Dr. Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration, said Tuesday during a Senate hearing on the federal coronavirus response, the Times reported.

“We believe all of them detect Omicron,” she said. “We simply feel they are somewhat less sensitive than they were to some of the previous variants.”

But the new research, done with nasal swabs, does not address how early in an infection the rapid tests can spot the variant, or whether they would perform better with saliva samples. Also, the BinaxNOW results cannot be extrapolated to other rapid tests, which must be evaluated individually, the researchers noted.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on COVID tests.


SOURCE: The New York Times




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net